loading
前日終値:
$7.39
開ける:
$7.17
24時間の取引高:
266.70K
Relative Volume:
0.60
時価総額:
$582.74M
収益:
$14.02M
当期純損益:
$-84.03M
株価収益率:
-4.9864
EPS:
-1.47
ネットキャッシュフロー:
$-125.54M
1週間 パフォーマンス:
-3.04%
1か月 パフォーマンス:
+5.01%
6か月 パフォーマンス:
+72.07%
1年 パフォーマンス:
+20.76%
1日の値動き範囲:
Value
$7.05
$7.53
1週間の範囲:
Value
$7.05
$7.95
52週間の値動き範囲:
Value
$3.85
$8.75

Meiragtx Holdings Plc Stock (MGTX) Company Profile

Name
名前
Meiragtx Holdings Plc
Name
セクター
Healthcare (1166)
Name
電話
646-860-7985
Name
住所
450 EAST 29TH STREET, NEW YORK, NY
Name
職員
0
Name
Twitter
@MeiraGTx
Name
次回の収益日
2025-03-12
Name
最新のSEC提出書
Name
MGTX's Discussions on Twitter

MGTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MGTX
Meiragtx Holdings Plc
7.33 582.74M 14.02M -84.03M -125.54M -1.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-07-31 再開されました Chardan Capital Markets Buy
2020-10-23 開始されました RBC Capital Mkts Outperform
2020-09-15 再開されました BofA Securities Buy
2019-09-03 開始されました Piper Jaffray Overweight
2019-02-27 繰り返されました Chardan Capital Markets Buy
2018-07-03 開始されました Barclays Overweight
2018-07-03 開始されました BofA/Merrill Buy
すべてを表示

Meiragtx Holdings Plc (MGTX) 最新ニュース

pulisher
Mar 28, 2025

Chardan Capital Comments on MeiraGTx FY2026 Earnings - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Position Increased by Bank of New York Mellon Corp - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

Chardan Capital Forecasts MeiraGTx FY2025 Earnings - Defense World

Mar 27, 2025
pulisher
Mar 25, 2025

MeiraGTx Holdings: Gaining Regulatory Focus (NASDAQ:MGTX) - Seeking Alpha

Mar 25, 2025
pulisher
Mar 24, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future - Yahoo Finance

Mar 24, 2025
pulisher
Mar 22, 2025

Reviewing MeiraGTx (NASDAQ:MGTX) and CRISPR Therapeutics (NASDAQ:CRSP) - Defense World

Mar 22, 2025
pulisher
Mar 18, 2025

MeiraGTx (NASDAQ:MGTX) Given New $13.00 Price Target at Royal Bank of Canada - Defense World

Mar 18, 2025
pulisher
Mar 18, 2025

MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment - Insider Monkey

Mar 18, 2025
pulisher
Mar 17, 2025

RBC Capital raises MeiraGTx stock price target to $13.00 By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

RBC Capital raises MeiraGTx stock price target to $13.00 - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

RBC Raises Price Target on MeiraGTx Holdings to $13 From $11, Keeps Outperform, Speculative Risk - Marketscreener.com

Mar 17, 2025
pulisher
Mar 16, 2025

When the Price of (MGTX) Talks, People Listen - Stock Traders Daily

Mar 16, 2025
pulisher
Mar 16, 2025

MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume – Here’s Why - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

Top 10 AI News Updates Taking Wall Street By Storm - Insider Monkey

Mar 14, 2025
pulisher
Mar 14, 2025

Plaudits For MeiraGTx And Its Parkinson’s AI Pact - News & Insights

Mar 14, 2025
pulisher
Mar 14, 2025

US$200M Deal Accelerates Phase 3 Gene Therapy for Parkinsons - Streetwise Reports

Mar 14, 2025
pulisher
Mar 14, 2025

MeiraGTx Holdings plc's (NASDAQ:MGTX) 29% Price Boost Is Out Of Tune With Revenues - Simply Wall St

Mar 14, 2025
pulisher
Mar 13, 2025

MGTX stock touches 52-week high of $7.9 amid market optimism - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Shares Soar After Joint Venture Deal With Hologen -March 13, 2025 at 03:31 pm EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Top Midday Gainers -March 13, 2025 at 02:24 pm EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

MGTX’s price-to-sales ratio: A comparative analysis with its peers - US Post News

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Holdings plc SEC 10-K Report - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx earnings beat by $0.08, revenue topped estimates - Investing.com UK

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars - Benzinga India

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx (MGTX) Stock Climbs in Pre-Hour Trading - Stocks Telegraph

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx secures $200 million, forms joint venture for CNS drugs By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Secures $200 Mln From Hologen For Phase 3 Dvpt. Of AAV-GAD, Establish Neuro-AI JV - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Holdings PLC reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Holdings Announces Joint Venture with Hologen - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx secures $200 million, forms joint venture for CNS drugs - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx stock surges on Hologen AI deal By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx stock surges on Hologen AI deal - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson's Disease and Industrialize MeiraGTx's Proprietary Manufacturing Process - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx and Hologen Limited Announce $200 Million Collaboration and Formation of Hologen Neuro AI Ltd Joint Venture for Parkinson's Disease Development - Nasdaq

Mar 13, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains Overweight on MeiraGTx stock, $26 target By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains Overweight on MeiraGTx stock, $26 target - Investing.com India

Mar 12, 2025
pulisher
Mar 10, 2025

MeiraGTx Holdings PLC expected to post a loss of 56 cents a shareEarnings Preview - TradingView

Mar 10, 2025
pulisher
Mar 10, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Purchased by Rhumbline Advisers - Defense World

Mar 10, 2025
pulisher
Mar 06, 2025

MeiraGTx (MGTX) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

(MGTX) Investment Analysis - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 04, 2025

2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies - GlobeNewswire Inc.

Mar 04, 2025
pulisher
Feb 27, 2025

MeiraGTx (NASDAQ:MGTX) Receives "Buy" Rating from Chardan Capital - MarketBeat

Feb 27, 2025
pulisher
Feb 25, 2025

MeiraGTx Holdings plc (MGTX) expanding its growth trajectory ahead - SETE News

Feb 25, 2025
pulisher
Feb 25, 2025

MeiraGTx’s (MGTX) Buy Rating Reaffirmed at Chardan Capital - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

MeiraGTx seeks UK approval after gene therapy restores sight in children born blind - Yahoo Finance

Feb 24, 2025
pulisher
Feb 23, 2025

MeiraGTx (NASDAQ:MGTX) Reaches New 52-Week High – What’s Next? - Defense World

Feb 23, 2025
pulisher
Feb 21, 2025

MeiraGTx rises after publication of positive data from gene therapy trial for eye disorder - Seeking Alpha

Feb 21, 2025
pulisher
Feb 21, 2025

Meiragtx’s gene therapy shows ‘exceptional’ data for blind children - BioWorld Online

Feb 21, 2025
pulisher
Feb 21, 2025

MGTX stock soars to 52-week high, reaching $7.39 - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

MGTX stock soars to 52-week high, reaching $7.39 By Investing.com - Investing.com Canada

Feb 21, 2025

Meiragtx Holdings Plc (MGTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):